ICON plc (ICLR) PT Raised to $154 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ICON plc (ICLR) Buys MolecularMD Corporation
February 21, 2019 10:03 AM ESTMolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation of precision medicines in oncology, announced today that it has been acquired by ICON plc (NASDAQ: ICLR). MolecularMDs extensive scientific and clinical biomarker experience expands ICONs capabilities in molecular diagnostic testing and also adds expanded testing platforms, including next-generation sequencing and immunohistochemistry, to ICONs laboratory service offering. MolecularMDs specialty central laboratory offering and associated client base extends ICONs reach into the support of precision... More
ICON plc (ICLR) Tops Q4 EPS by 3c, Reaffirms Guidance
February 20, 2019 4:32 PM ESTICON plc (NASDAQ: ICLR) reported Q4 EPS of $1.63, $0.03 better than the analyst estimate of $1.60. Revenue for the quarter came in at $679 million versus the consensus estimate of $675.88 million.
2019 outlook reaffirmed with revenue guidance in the range of $2,735 - $2,835 million and earnings per... More